Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s stock price shot up 0.5% on Wednesday. The stock traded as high as €35.08 and last traded at €35.00. Approximately 106,616 shares changed hands during trading, an increase of 13% from the average daily volume of 94,405 shares. The stock had previously closed at €34.84.
Carl Zeiss Meditec Price Performance
The firm has a market capitalization of $3.26 billion, a price-to-earnings ratio of 18.70, a PEG ratio of 2.83 and a beta of 1.33. The firm’s fifty day moving average is €32.16 and its 200 day moving average is €28.56.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
